PMID- 9286342 OWN - NLM STAT- MEDLINE DCOM- 19971114 LR - 20190622 IS - 0065-2598 (Print) IS - 0065-2598 (Linking) VI - 417 DP - 1997 TI - Regulation of CD44 isoform expression and CD44-mediated signaling in human dendritic cells. PG - 83-90 AB - Dendritic cells (DCs) express CD44, a cell surface receptor for the extracellular matrix ligand hyaluronate, involved in cell-cell interactions and cell migration. Besides the "standard" form of CD44, a variety of splice variants contain an additional extracellular region encoded by 10 "variable" exons termed v1 to v10. The standard form of CD44 as well as variants containing exon v6 (CD44v6) are known to play important roles in the immune system, yet largely unexplored in the DC lineage. In this study, we examined the regulation of CD44 isoforms in human DCs derived from monocytes cultivated in the presence of GM-CSF and IL-4. We found that v3, v6 and v9 variants are all up-regulated upon TNF-alpha stimulation of DCs. In addition, we show that stimulation of DCs using anti-CD44 mAbs can induce DC agregation, up-regulation of accessory molecule expression and secretion of cytokines. A mAb directed against CD44v6 variants was shown to mediate some of these effects. FAU - Haegel-Kronenberger, H AU - Haegel-Kronenberger H AD - INSERM CJF 94-03, Strasbourg, France. FAU - de la Salle, H AU - de la Salle H FAU - Bohbot, A AU - Bohbot A FAU - Galon, J AU - Galon J FAU - Tartour, E AU - Tartour E FAU - Cazenave, J P AU - Cazenave JP FAU - Hanau, D AU - Hanau D LA - eng PT - Journal Article PL - United States TA - Adv Exp Med Biol JT - Advances in experimental medicine and biology JID - 0121103 RN - 0 (Antibodies, Monoclonal) RN - 0 (Cytokines) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Hyaluronan Receptors) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Antibodies, Monoclonal/pharmacology MH - Cell Aggregation MH - Cell Differentiation/drug effects MH - Cytokines/biosynthesis MH - Dendritic Cells/cytology/drug effects/*immunology MH - Genetic Variation MH - Histocompatibility Antigens Class II/metabolism MH - Humans MH - Hyaluronan Receptors/*genetics/*metabolism MH - In Vitro Techniques MH - Phenotype MH - RNA, Messenger/genetics MH - Signal Transduction MH - Tumor Necrosis Factor-alpha/pharmacology MH - Up-Regulation/drug effects EDAT- 1997/01/01 00:00 MHDA- 1997/01/01 00:01 CRDT- 1997/01/01 00:00 PHST- 1997/01/01 00:00 [pubmed] PHST- 1997/01/01 00:01 [medline] PHST- 1997/01/01 00:00 [entrez] AID - 10.1007/978-1-4757-9966-8_14 [doi] PST - ppublish SO - Adv Exp Med Biol. 1997;417:83-90. doi: 10.1007/978-1-4757-9966-8_14.